{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:17:23Z","timestamp":1791983843418,"version":"4.4.0"},"reference-count":35,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,2]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>HSP90 inhibition induces apoptosis in BL cells by disrupting tonic BCR signaling. SYK is an HSP90 client protein, and BCR signaling-dependent phosphorylation of HSP90 on Y197 is required for this interaction.<\/jats:p>","DOI":"10.1182\/blood-2016-06-721423","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T07:55:33Z","timestamp":1479282933000},"page":"598-608","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling"],"prefix":"10.1182","volume":"129","author":[{"given":"Roland","family":"Walter","sequence":"first","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ting","family":"Pan","sequence":"additional","affiliation":[{"name":"Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Doebele","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-6610","authenticated-orcid":false,"given":"Federico","family":"Comoglio","sequence":"additional","affiliation":[{"name":"Department of Haematology, University of Cambridge, Cambridge, United Kingdom;"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council Stem Cell Institute, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Tomska","sequence":"additional","affiliation":[{"name":"Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanibal","family":"Bohnenberger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Young","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jacobs","sequence":"additional","affiliation":[{"name":"III Medical Department, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[{"name":"III Medical Department, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvard","family":"B\u00f6nig","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Engelke","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Immunology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"},{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Urlaub","sequence":"additional","affiliation":[{"name":"Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, G\u00f6ttingen, Germany;"},{"name":"Bioanalytics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Consortium\/ German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany;"},{"name":"German Cancer Consortium\/ German Cancer Research Center, Heidelberg, Germany;"},{"name":"Department of Medicine V, Heidelberg University Medical Center, Heidelberg, Germany; and"},{"name":"European Molecular Biology Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"Department of Haematology, University of Cambridge, Cambridge, United Kingdom;"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council Stem Cell Institute, Cambridge, United Kingdom;"},{"name":"German Cancer Consortium\/ German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111903334106600_B1","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"26","key":"2019111903334106600_B2","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","article-title":"Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial","volume":"124","author":"Hoelzer","year":"2014","journal-title":"Blood"},{"issue":"7418","key":"2019111903334106600_B3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"6","key":"2019111903334106600_B4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"issue":"20","key":"2019111903334106600_B5","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1073\/pnas.1601053113","article-title":"Elucidation of tonic and activated B-cell receptor signaling in Burkitt\u2019s lymphoma provides insights into regulation of cell survival","volume":"113","author":"Corso","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5870","key":"2019111903334106600_B6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"7277","key":"2019111903334106600_B7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"41","key":"2019111903334106600_B8","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1038\/sj.onc.1208779","article-title":"Nfkb 1 is dispensable for Myc-induced lymphomagenesis","volume":"24","author":"Keller","year":"2005","journal-title":"Oncogene"},{"issue":"12","key":"2019111903334106600_B9","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2008-09-181008","article-title":"The IKK2\/NF-kappaB pathway suppresses MYC-induced lymphomagenesis","volume":"114","author":"Klapproth","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111903334106600_B10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"2019111903334106600_B11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.27675","article-title":"High-throughput SNP-based authentication of human cell lines","volume":"132","author":"Castro","year":"2013","journal-title":"Int J Cancer"},{"issue":"7","key":"2019111903334106600_B12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1074\/mcp.M800567-MCP200","article-title":"SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins","volume":"8","author":"Oellerich","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"2019111903334106600_B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nbt1046","article-title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells","volume":"23","author":"Rush","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2019111903334106600_B14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/ac026117i","article-title":"Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics","volume":"75","author":"Rappsilber","year":"2003","journal-title":"Anal Chem"},{"issue":"12","key":"2019111903334106600_B15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2019111903334106600_B16","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J Proteome Res"},{"issue":"17","key":"2019111903334106600_B17","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1038\/emboj.2011.251","article-title":"The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85","volume":"30","author":"Oellerich","year":"2011","journal-title":"EMBO J"},{"issue":"11","key":"2019111903334106600_B18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-007-0313-7","article-title":"A human Burkitt\u2019s lymphoma cell line carrying t(8;22) and t(14;18) translocations","volume":"86","author":"Kiefer","year":"2007","journal-title":"Ann Hematol"},{"issue":"7","key":"2019111903334106600_B19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"2019111903334106600_B20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"2019111903334106600_B21","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2007.11.7960","article-title":"Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study","volume":"25","author":"Modi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"20","key":"2019111903334106600_B22","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.0903392106","article-title":"Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models","volume":"106","author":"Caldas-Lopes","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111903334106600_B23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.CCR-14-0979","article-title":"First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors","volume":"21","author":"Shapiro","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111903334106600_B24","doi-asserted-by":"crossref","first-page":"M111.016675","DOI":"10.1074\/mcp.M111.016675","article-title":"Systematic identification of the HSP90 candidate regulated proteome","volume":"11","author":"Wu","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"6797","key":"2019111903334106600_B25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/35021086","article-title":"The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells","volume":"406","author":"Coopman","year":"2000","journal-title":"Nature"},{"issue":"5","key":"2019111903334106600_B26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","author":"Taipale","year":"2012","journal-title":"Cell"},{"issue":"6","key":"2019111903334106600_B27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.molcel.2011.02.011","article-title":"Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity","volume":"41","author":"Mollapour","year":"2011","journal-title":"Mol Cell"},{"issue":"3","key":"2019111903334106600_B28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.molcel.2012.05.015","article-title":"Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine","volume":"47","author":"Xu","year":"2012","journal-title":"Mol Cell"},{"issue":"4","key":"2019111903334106600_B29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V97.4.1050","article-title":"Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)","volume":"97","author":"Kuno","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2019111903334106600_B30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.leu.2403266","article-title":"TEL-Syk fusion constitutively activates PI3-K\/Akt, MAPK and JAK2-independent STAT5 signal pathways","volume":"18","author":"Kanie","year":"2004","journal-title":"Leukemia"},{"issue":"11","key":"2019111903334106600_B31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nchembio.670","article-title":"Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90","volume":"7","author":"Moulick","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"8","key":"2019111903334106600_B32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/annonc\/mdv220","article-title":"A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)","volume":"26","author":"Ramalingam","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"2019111903334106600_B33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjh.13427","article-title":"Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma","volume":"170","author":"Zhang","year":"2015","journal-title":"Br J Haematol"},{"issue":"21","key":"2019111903334106600_B34","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2014-10-605808","article-title":"Secondary mutations as mediators of resistance to targeted therapy in leukemia","volume":"125","author":"Daver","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111903334106600_B35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.beha.2010.01.007","article-title":"Signalling to drug resistance in CLL","volume":"23","author":"Hertlein","year":"2010","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/5\/598\/1401213\/blood721423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/5\/598\/1401213\/blood721423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:34:12Z","timestamp":1574134452000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/5\/598\/36155\/HSP90-promotes-Burkitt-lymphoma-cell-survival-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-06-721423","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}